everio 25 mikrogramov/125 mikrogramov/dávka inhalačná suspenzia v tlakovom obale
zentiva, k.s., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
asthmex 50 mikrogramov/500 mikrogramov dávkovaný inhalačný prášok
glenmark pharmaceuticals s.r.o., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
asthmex 50 mikrogramov/250 mikrogramov dávkovaný inhalačný prášok
glenmark pharmaceuticals s.r.o., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
asthmex 50 mikrogramov/100 mikrogramov dávkovaný inhalačný prášok
glenmark pharmaceuticals s.r.o., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
everio airmaster 50 mikrogramov/100 mikrogramov
zentiva k.s., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
everio airmaster 50 mikrogramov/250 mikrogramov
zentiva k.s., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
zoreeda ciphaler 50 mikrogramov/500 mikrogramov dávkovaný inhalačný prášok
elc group s.r.o., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
zoreeda ciphaler 50 mikrogramov/250 mikrogramov dávkovaný inhalačný prášok
elc group s.r.o., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
airexar spiromax
teva b.v. - salmeterol, fluticasone propionatas - pulmonary disease, chronic obstructive; asthma - vaistai nuo obstrukcinių kvėpavimo takų ligų, - airexar spiromax skirtas vartoti tik suaugusiesiems nuo 18 metų ir vyresnių. asthmaairexar spiromax is indicated for the regular treatment of patients with severe asthma where use of a combination product (inhaled corticosteroid and long-acting β2 agonist) is appropriate:- patients not adequately controlled on a lower strength corticosteroid combination productor- patients already controlled on a high dose inhaled corticosteroid and long-acting β2 agonist. lėtinė obstrukcinė plaučių liga (lopl)airexar spiromax fluorouracilu ir simptominis gydymas pacientams, sergantiems lopl, su fev1.
airexar spiromax
teva b.v. - salmeterol, flútikasón nef - pulmonary disease, chronic obstructive; asthma - lyf til veikindi öndunarvegi sjúkdómum, - airexar spiromax er ætlað til notkunar hjá fullorðnum 18 ára og eldri. asthmaairexar spiromax is indicated for the regular treatment of patients with severe asthma where use of a combination product (inhaled corticosteroid and long-acting β2 agonist) is appropriate:- patients not adequately controlled on a lower strength corticosteroid combination productor- patients already controlled on a high dose inhaled corticosteroid and long-acting β2 agonist. langvinn veikindi í lungum (llt)airexar viðeigandi er ætlað til meðferð við sjúklinga með llt, með fev1.